Autoimmune Diseases

Companies Autoimmune Diseases

Biomol GmbH, Germany

Biomol GmbH offers antibodies, enzymes, bioactive lipids, microarrays and reagents for biomedical research. Our focus is on cellular regulation and signal transduction. Together with our partners, we also provide a variety of specialized kits for drug discovery. more

News Autoimmune Diseases

• BGU researchers have discovered how prolonged exposure to stress can increase the risk of autoimmune diseases

  Ben-Gurion University of the Negev researchers have proven that chronic stress increases the susceptibility to an autoimmune disease similar to multiple sclerosis, which is characterized by damage to the nervous system in the brain. The researchers, Dr. Idan Harpaz and Prof. Alon Monsonego, in conju more

• Video reveals cancer cells' Achilles' heel
  

  Scientists from the Manchester Collaborative Centre for Inflammation Research (MCCIR) have discovered why a particular cancer drug is so effective at killing cells. Their findings could be used to aid the design of future cancer treatments. Professor Daniel Davis and his team used high quality video more

• Exposed region is indispensable

  A team headed by Prof. Dr. Wolfgang Schamel from the Institute of Biology III of the University of Freiburg and Prof. Dr. Balbino Alarcón from the Center for Molecular Biology Severo Ochoa of the Autonomous University of Madrid has succeeded in explaining an important step in the activation of the s more

White papers Autoimmune Diseases

• The xCELLigence System: Label-Free Measurement of Natural Killer Cell Cytotoxic Activity in Real Time
  

  Natural killer (NK) cells have been implicated in the recognition and annihilation of tumor cells. The assessment of the cytolytic activity of NK cells is important not only for monitoring of immunocompetence in cancer, infectious diseases, and autoimmune diseases, but also in determining the proteins which mediate the cytolytic effect. more

Publications Autoimmune Diseases

• The Impact of Genetic Susceptibility to Systemic Lupus Erythematosus on Placental Malaria in Mice

  by Michael Waisberg, Christina K. Lin, Chiung-Yu Huang, Mirna Pena, Marlene Orandle, Silvia Bolland, Susan K. Pierce Severe malaria, including cerebral malaria (CM) and placental malaria (PM), have been recognized to have many of the features of uncontrolled inflammation. We recently showed that more

• Developmental maturation of innate immune cell function correlates with susceptibility to central nervous system autoimmunity

  Multiple sclerosis (MS) is an inflammatory central nervous system (CNS) disorder which typically occurs in early adulthood and rarely in children. Here we tested whether functional maturation of innate immune cells may determine susceptibility to CNS autoimmune disease in experimental autoimmune e more

• Crohn's Disease Loci Are Common Targets of Protozoa-Driven Selection

  Previous studies indicated that a few risk variants for autoimmune diseases are subject to pathogen-driven selection. Nonetheless, the proportion of risk loci that has been targeted by pathogens and the type of infectious agent(s) that exerted the strongest pressure remain to be evaluated. We asses more

Market studies Autoimmune Diseases

• Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards

  GBI Research’s new report, “Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards”, provides in-depth analysis of the unmet needs, drivers and barriers that impact the global gene therapy market. The report analyzes more

• Immunomodulators Market to 2017 - Immunosuppressant Antibodies to Replace Antimetabolites as the Highest Value Sector by 2017

  Leading business intelligence provider GBI Research has released its latest research report, “Immunomodulators Market to 2017 - Immunosuppressant Antibodies to Replace Antimetabolites as the Highest Value Sector by 2017”, which provides insight about immunomodulators sales forecasts until 2017.I Imm more

• Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments

  GBI Research, the leading business intelligence provider, has released its latest research “Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments”, which provides insights into more

Websites Autoimmune Diseases